These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


776 related items for PubMed ID: 11756651

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC, Wood J, Mandriota SJ, Schnell C, Ferrari S, Mestan J, Zhu Z, Witte L, Pepper MS.
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
    Guo P, Xu L, Pan S, Brekken RA, Yang ST, Whitaker GB, Nagane M, Thorpe PE, Rosenbaum JS, Su Huang HJ, Cavenee WK, Cheng SY.
    Cancer Res; 2001 Dec 01; 61(23):8569-77. PubMed ID: 11731444
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression.
    Miao HQ, Lee P, Lin H, Soker S, Klagsbrun M.
    FASEB J; 2000 Dec 01; 14(15):2532-9. PubMed ID: 11099472
    [Abstract] [Full Text] [Related]

  • 27. Regulation of retinal vascular endothelial growth factor and receptors in rabbits exposed to hyperoxia.
    Ozaki NK, Beharry KD, Nishihara KC, Akmal Y, Ang JG, Sheikh R, Modanlou HD.
    Invest Ophthalmol Vis Sci; 2002 May 01; 43(5):1546-57. PubMed ID: 11980873
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
    Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, Tonn JC, Menger MD, Breier G.
    J Clin Invest; 2002 Mar 01; 109(6):777-85. PubMed ID: 11901186
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY.
    Life Sci; 2006 Nov 17; 79(25):2370-81. PubMed ID: 16959272
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. VEGF receptor signaling and endothelial function.
    Kliche S, Waltenberger J.
    IUBMB Life; 2001 Jul 17; 52(1-2):61-6. PubMed ID: 11795595
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma.
    Strizzi L, Catalano A, Vianale G, Orecchia S, Casalini A, Tassi G, Puntoni R, Mutti L, Procopio A.
    J Pathol; 2001 Apr 17; 193(4):468-75. PubMed ID: 11276005
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Expression of vascular endothelial growth factor and its receptors is increased, but microvascular relaxation is impaired in patients after acute myocardial ischemia.
    Xu X, Li J, Simons M, Li J, Laham RJ, Sellke FW.
    J Thorac Cardiovasc Surg; 2001 Apr 17; 121(4):735-42. PubMed ID: 11279416
    [Abstract] [Full Text] [Related]

  • 40. Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions.
    Yamagishi S, Yonekura H, Yamamoto Y, Fujimori H, Sakurai S, Tanaka N, Yamamoto H.
    Lab Invest; 1999 Apr 17; 79(4):501-9. PubMed ID: 10212003
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 39.